For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Co-Diagnostics Inc (NASDAQ: CODX) closed at $0.28 up 3.29% from its previous closing price of $0.27. In other words, the price has increased by $3.29 from its previous closing price. On the day, 0.65 million shares were traded. CODX stock price reached its highest trading level at $0.2876 during the session, while it also had its lowest trading level at $0.2572.
Ratios:
For a deeper understanding of Co-Diagnostics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.23 and its Current Ratio is at 4.43. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 9426015 and an Enterprise Value of -10121750. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.54 while its Price-to-Book (P/B) ratio in mrq is 0.20. Its current Enterprise Value per Revenue stands at -2.894 whereas that against EBITDA is 0.273.
Stock Price History:
The Beta on a monthly basis for CODX is 0.58, which has changed by -0.80689657 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $2.23, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is -11.65%, while the 200-Day Moving Average is calculated to be -62.65%.
Shares Statistics:
For the past three months, CODX has traded an average of 366.04K shares per day and 438690 over the past ten days. A total of 33.57M shares are outstanding, with a floating share count of 30.68M. Insiders hold about 9.00% of the company’s shares, while institutions hold 17.44% stake in the company. Shares short for CODX as of 1748563200 were 391378 with a Short Ratio of 1.07, compared to 1745971200 on 139008. Therefore, it implies a Short% of Shares Outstanding of 391378 and a Short% of Float of 1.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Co-Diagnostics Inc (CODX) is the result of assessments by 1.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.68 and -$0.68 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.34, with 1.0 analysts recommending between -$0.34 and -$0.34.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $300k this quarter.It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, Co-Diagnostics Inc’s year-ago sales were $2.66MFor the next quarter, 1 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $950k, while the lowest revenue estimate was $950k, resulting in an average revenue estimate of $950k. In the same quarter a year ago, actual revenue was $3.92M
